Literature DB >> 20124119

Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder.

Jamie D Feusner1, Teena Moody, Emily Hembacher, Jennifer Townsend, Malin McKinley, Hayley Moller, Susan Bookheimer.   

Abstract

CONTEXT: Body dysmorphic disorder (BDD) is a psychiatric disorder in which individuals are preoccupied with perceived defects in their appearance, often related to their face. Little is known about its pathophysiology, although early research provides evidence of abnormal visual processing.
OBJECTIVE: To determine whether patients with BDD have abnormal patterns of brain activation when visually processing their own face with high, low, or normal spatial resolution.
DESIGN: Case-control study.
SETTING: A university hospital. PARTICIPANTS: Seventeen right-handed medication-free subjects with BDD and 16 matched healthy control subjects. Intervention Functional magnetic resonance imaging while viewing photographs of face stimuli. Stimuli were neutral-expression photographs of the patient's own face and a familiar face (control stimuli) that were unaltered, altered to include only high spatial frequency (fine spatial resolution), or altered to include only low spatial frequency (low spatial resolution). MAIN OUTCOME MEASURE: Blood oxygen level-dependent signal changes in the BDD and control groups during each stimulus type.
RESULTS: Subjects with BDD showed relative hyperactivity in the left orbitofrontal cortex and bilateral head of the caudate for the unaltered own-face vs familiar-face condition. They showed relative hypoactivity in the left occipital cortex for the low spatial frequency faces. Differences in activity in frontostriatal systems but not visual cortex covaried with aversiveness ratings of the faces. Severity of BDD symptoms correlated with activity in frontostriatal systems and visual cortex.
CONCLUSIONS: These results suggest abnormalities in visual processing and frontostriatal systems in BDD. Hypoactivation in the occipital cortex for low spatial frequency faces may indicate either primary visual system abnormalities for configural face elements or top-down modulation of visual processing. Frontostriatal hyperactivity may be associated both with aversion and with symptoms of obsessive thoughts and compulsive behaviors.

Entities:  

Mesh:

Year:  2010        PMID: 20124119      PMCID: PMC2853756          DOI: 10.1001/archgenpsychiatry.2009.190

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  54 in total

Review 1.  Integrated model of visual processing.

Authors:  J Bullier
Journal:  Brain Res Brain Res Rev       Date:  2001-10

2.  Computerized perceptual analysis of patients with body dysmorphic disorder: a pilot study.

Authors:  Jose A Yaryura-Tobias; Fugen Neziroglu; Robert Chang; Sean Lee; Anthony Pinto; Laura Donohue
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

3.  Cortical mechanisms of visual self-recognition.

Authors:  Motoaki Sugiura; Jobu Watanabe; Yasuhiro Maeda; Yoshihiko Matsue; Hiroshi Fukuda; Ryuta Kawashima
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

4.  The variability of human, BOLD hemodynamic responses.

Authors:  G K Aguirre; E Zarahn; M D'esposito
Journal:  Neuroimage       Date:  1998-11       Impact factor: 6.556

5.  A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery.

Authors:  S L Rauch; B A van der Kolk; R E Fisler; N M Alpert; S P Orr; C R Savage; A J Fischman; M A Jenike; R K Pitman
Journal:  Arch Gen Psychiatry       Date:  1996-05

6.  Prevalence of body dysmorphic disorder in patients with anxiety disorders.

Authors:  S Wilhelm; M W Otto; B G Zucker; M H Pollack
Journal:  J Anxiety Disord       Date:  1997 Sep-Oct

7.  A neuromodulatory role for the human amygdala in processing emotional facial expressions.

Authors:  J S Morris; K J Friston; C Büchel; C D Frith; A W Young; A J Calder; R J Dolan
Journal:  Brain       Date:  1998-01       Impact factor: 13.501

8.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.

Authors:  S L Rauch; M A Jenike; N M Alpert; L Baer; H C Breiter; C R Savage; A J Fischman
Journal:  Arch Gen Psychiatry       Date:  1994-01

Review 9.  Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Authors:  Lara Menzies; Samuel R Chamberlain; Angela R Laird; Sarah M Thelen; Barbara J Sahakian; Ed T Bullmore
Journal:  Neurosci Biobehav Rev       Date:  2007-10-17       Impact factor: 8.989

10.  Spatial frequency and face processing in children with autism and Asperger syndrome.

Authors:  Christine Deruelle; Cecilie Rondan; Bruno Gepner; Carole Tardif
Journal:  J Autism Dev Disord       Date:  2004-04
View more
  54 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Visual processing in anorexia nervosa and body dysmorphic disorder: similarities, differences, and future research directions.

Authors:  Sarah K Madsen; Cara Bohon; Jamie D Feusner
Journal:  J Psychiatr Res       Date:  2013-06-27       Impact factor: 4.791

3.  Psychological treatment of social anxiety disorder improves body dysmorphic concerns.

Authors:  Angela Fang; Alice T Sawyer; Idan M Aderka; Stefan G Hofmann
Journal:  J Anxiety Disord       Date:  2013-08-06

Review 4.  Perceived ugliness: an update on treatment-relevant aspects of body dysmorphic disorder.

Authors:  Ulrike Buhlmann; Anna Winter
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

5.  Comparison of visual perceptual organization in schizophrenia and body dysmorphic disorder.

Authors:  Steven M Silverstein; Corinna M Elliott; Jamie D Feusner; Brian P Keane; Deepthi Mikkilineni; Natasha Hansen; Andrea Hartmann; Sabine Wilhelm
Journal:  Psychiatry Res       Date:  2015-06-27       Impact factor: 3.222

6.  A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.

Authors:  Katharine A Phillips; Anthony Pinto; Ashley S Hart; Meredith E Coles; Jane L Eisen; William Menard; Steven A Rasmussen
Journal:  J Psychiatr Res       Date:  2012-07-21       Impact factor: 4.791

7.  Inverted face processing in body dysmorphic disorder.

Authors:  Jamie D Feusner; Hayley Moller; Lily Altstein; Catherine Sugar; Susan Bookheimer; Joanne Yoon; Emily Hembacher
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

Review 8.  Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia.

Authors:  Steven M Silverstein; Bita Moghaddam; Til Wykes
Journal:  Schizophr Bull       Date:  2014-01-28       Impact factor: 9.306

Review 9.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

10.  Abnormal brain network organization in body dysmorphic disorder.

Authors:  Donatello Arienzo; Alex Leow; Jesse A Brown; Liang Zhan; Johnson Gadelkarim; Sarit Hovav; Jamie D Feusner
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.